Investical Earnings & investing calendar Earnings & investing calendar
/
OONO PHARMACEUTICAL CO.,LTD. logo
4528TSE Prime

ONO PHARMACEUTICAL CO.,LTD.

小野薬品工業 Yahoo Finance

Recent & upcoming events

Oct 29
Earnings 2:00
Q2 earnings announcement (scheduled)
Add to Google Calendar
Sep 28
Ex-dividend Time TBD
Ex-rights date (interim)
Add to Google Calendar
Sep 27
Dividend Time TBD
Last day with rights (interim)
Add to Google Calendar
Jul 31
Earnings 2:00
Q1 earnings announcement (scheduled)
Add to Google Calendar
Jun 17
Shareholder meeting Time TBD
Shareholders' meeting
Add to Google Calendar
May 8
Earnings 2:00
FY earnings announcement (scheduled)
Add to Google Calendar
Jan 22
Est.
Earnings 1:00 approx.
Q3 earnings
Add to Google Calendar
Mar 28
Est.
Dividend Time TBD
Last day with rights (year-end)
Add to Google Calendar
Mar 29
Est.
Ex-dividend Time TBD
Ex-rights date (year-end)
Add to Google Calendar
Apr 16
Est.
Earnings 2:00 approx.
Full-year earnings
Add to Google Calendar
Jul 9
Est.
Earnings 2:00 approx.
Q1 earnings
Add to Google Calendar
Sep 27
Est.
Dividend Time TBD
Last day with rights (interim)
Add to Google Calendar
Sep 28
Est.
Ex-dividend Time TBD
Ex-rights date (interim)
Add to Google Calendar
Oct 1
Est.
Earnings 2:00 approx.
Earnings announcement (predicted)
Add to Google Calendar
Past events
2026
Oct 29
Earnings 2:00
Q2 earnings announcement (scheduled)
Add to Google Calendar

KPI highlights

FY26
Revenue ¥515.78B YoY +5.9%
Operating income ¥92.24B margin 17.9%
Net income ¥69.77B YoY +39.4%
EPS ¥148 YoY +39.4%
P/E —
ROE 8.5% Equity ratio 77% Typical equity ratios vary a lot by industry. Banks, brokerages, and other financial companies tend to run lower ratios because leverage (using other people's capital) is core to their business model — a low ratio there isn't a sign of financial weakness.

Company guidance

FY2027/03 Company-issued full-year guidance (from earnings report) / %=vs prior FY
Revenue ¥455.00B -11.8%
Operating income ¥94.00B +1.9%
Net income ¥71.00B +1.8%
EPS ¥151 +1.8%

Quarterly fundamentals

Income & cash flow
Quarter FY23 Q2FY23 Q3FY23 Q4FY24 Q1FY24 Q2FY25 Q2
Revenue ¥120.02B¥138.70B¥131.19B¥112.77B——
Operating income ¥41.35B¥55.69B¥47.59B¥15.31B——
Net income ¥31.82B¥42.70B¥36.09B¥17.43B——
Operating CF ¥30.20B¥37.47B¥39.98B¥29.60B——

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)（2021–2026）

事業法人 3.4%国内機関 29.5%その他 3.4%未開示 60.7%202120222023202420252026
事業法人国内機関海外機関個人その他未開示・浮動株

「国内機関」は信託銀行の名義口座（年金・パッシブ・一部海外資本を含む）を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

日本マスタートラスト信託銀行株式会社 13.7%日本マスタートラスト信託銀行株式会社(信託口)株式会社日本カストディ銀行(信託口) 5.3%株式会社日本カストディ銀行(信託口)明治安田生命保険相互会社(常任代理人 3.9%明治安田生命保険相互会社(常任代理人株式会社日本カストディ銀行)公益財団法人小野奨学会 3.4%公益財団法人小野奨学会株式会社鶴鳴荘 3.4%株式会社鶴鳴荘ＪＰモルガン証券株式会社 3.1%ＪＰモルガン証券株式会社株式会社三菱ＵＦＪ銀行 1.8%株式会社三菱ＵＦＪ銀行日本マスタートラスト信託銀行株式会社 1.8%日本マスタートラスト信託銀行株式会社(株式付与ＥＳＯＰ信託口・80358口)ステート　ストリート　バンク　アンド 1.5%ステート　ストリート　バンク　アンド　トラスト　カンパニー　505001(常任代理人株式会社みずほ銀行)ビーエヌワイエム　アズ　エージーテイ 1.4%ビーエヌワイエム　アズ　エージーテイ　クライアンツ　10　パーセント(常任代理人株式会社三菱ＵＦＪ銀行)202120222023202420252026

Top shareholders — actual figures (as of 2026)

Holder Shares held Ratio Source
日本マスタートラスト信託銀行株式会社(信託口) 65,572,000 13.7% Yuho (EDINET)
株式会社日本カストディ銀行(信託口) 25,228,000 5.3% Yuho (EDINET)
明治安田生命保険相互会社 18,594,000 3.9% Yuho (EDINET)
公益財団法人小野奨学会 16,428,000 3.4% Yuho (EDINET)
株式会社鶴鳴荘 16,158,000 3.4% Yuho (EDINET)
JPモルガン証券株式会社 14,869,000 3.1% Yuho (EDINET)
株式会社三菱UFJ銀行 8,640,000 1.8% Yuho (EDINET)
日本マスタートラスト信託銀行株式会社(株式付与ESOP信託口・80358口) 8,398,000 1.8% Yuho (EDINET)
ステート ストリート バンク アンド トラスト カンパニー 505001 7,298,000 1.5% Yuho (EDINET)
ビーエヌワイエム アズ エージーテイ クライアンツ 10 パーセント 6,906,000 1.4% Yuho (EDINET)

Source：EDINET（大株主の状況）　Classification inferred from disclosed names

F-Score (Piotroski)

8/9

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

✓ Positive ROA ROA 6.3%
✓ Positive operating cash flow ¥136.82B
✓ ROA improved YoY 4.7% → 6.3%
✓ Operating CF exceeds net income (accrual quality) OCF ¥136.82B / net income ¥69.77B
✓ Equity ratio improved* Substitute for the original “decrease in long-term debt” 73.5% → 76.9%
✗ Current ratio improved 3.07× → 2.86×
✓ No dilution (shares outstanding did not increase) 498,692,000 → 498,692,000
✓ Gross margin improved 69.6% → 72.5%
✓ Asset turnover improved 0.46× → 0.47×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY26
Equity ratio 76.9%
Current ratio 2.9×
Years of positive operating CF 10 of last 10 yrs
Payout ratio 47%
Latest fiscal year result Profit (net income ¥69.77B)

Performance history

Last 10 years
0億円1,289億円2,579億円3,868億円5,158億円 FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

Income & assets

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
Revenue 2,4482,6182,8862,9243,0933,6144,4725,0274,8695,158
Operating income ——6207759831,0321,4201,599597922
Ordinary income ——————————
Net income 5585035155977548051,1271,280500698
Total assets 6,1756,0926,5516,7347,4687,3928,8249,13710,64011,065
Equity 5,1915,2445,5745,6256,3556,5597,4197,9307,8258,507

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Indicators & cash flow

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
EPS ¥105¥97¥100¥118¥151¥162¥231¥267¥107¥148
ROE 11.3%9.6%9.5%10.7%12.6%12.5%16.1%16.7%6.4%8.5%
Operating CF 7451576687427406181,5961,1078251,368
Investing CF -180-342-498-102-57660.4-1,003481-1,368-399
Financing CF -206-625-223-547-248-602-325-898943-655
FCF 565-1851706391646795941,587-543970

Source: EDINET (Annual Securities Report) (fetched 2026-08-29) *Some metrics supplemented from additional sources

Sector positioning

Relative standing within the sector
Is this information incorrect?

Data provided by Twelve Data